Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-026544
Filing Date
2019-05-15
Accepted
2019-05-15 16:05:26
Documents
2
Period of Report
2019-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv521684_form3.html 3  
1 FORM 3 tv521684_form3.xml 3 4845
2 EXHIBIT 24.1 tv521684_ex24-1.htm EX-24.1 9083
  Complete submission text file 0001144204-19-026544.txt   15578
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address
Koneru Mythili (Reporting) CIK: 0001776659 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37939 | Film No.: 19827980